Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-12

Clinical Trial Update: Efficacy of SN132D in Patients With Suspected Endometriosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating SN132D for suspected endometriosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SN132D (SN132D)

Snippet

Sponsor: Spago Nanomedical AB | Conditions: Endometriosis | Phase 2 | Status: COMPLETED